The impact of metabolic syndrome and triglyceride-glucose index on the risk of in-stent restenosis after percutaneous coronary intervention: a retrospective study. [PDF]
Front Cardiovasc MedHan L, Chen Y, Xu L, Chen W.
europepmc +1 more source
Radiomics features and clinical factors for predicting restenosis following endovascular therapy in patients with peripheral artery disease. [PDF]
BMC Med Inform Decis MakLuo M +7 more
europepmc +1 more source
Clinical efficacy of drug-eluting stents in the treatment of vertebral artery stenosis and analysis of factors contributing to stent restenosis. [PDF]
Front NeurolWei X +9 more
europepmc +1 more source
Association of Thyroid Function With Restenosis and Long-Term Outcomes After Drug-Coated Balloon Angioplasty in Euthyroid Patients With Coronary Heart Disease. [PDF]
Rev Cardiovasc MedDuan Y +6 more
europepmc +1 more source
Acquired external auditory canal stenosis: clinical characteristics, surgical strategies and prognostic analysis. [PDF]
Front PediatrMeng C, Lai R, Wu W, Yang S.
europepmc +1 more source
Glucocorticoid Therapy for Recurrent In-Stent Restenosis: A Prospective Explorative Case Series. [PDF]
JACC Case RepYu M +7 more
europepmc +1 more source
Comparison of carotid endarterectomy with primary closure versus patch angioplasty. [PDF]
BMC SurgParsa H, Maghsoudi LH, Chehre K.
europepmc +1 more source
Drug-coated balloons in coronary in-stent restenosis: a systematic review and meta-analysis comparing sirolimus and biolimus with paclitaxel platforms. [PDF]
Cardiovasc Interv TherDandamudi M +8 more
europepmc +1 more source
Unveiling the hidden: a surprising discovery in a patient with LAD in-stent restenosis. [PDF]
AsiaInterventionKaushik A +4 more
europepmc +1 more source